The Pharmacy and Poisons Board (PPB) of Kenya has issued a critical public alert regarding falsified Ozempic Pens, specifically Semaglutide products, which have unlawfully surfaced in the Kenyan market. These pens are not registered nor authorized for distribution in the country, raising serious concerns about their safety and efficacy.
Ozempic Pens, manufactured to treat type 2 diabetes by controlling blood sugar levels, are regulated health products that must meet stringent quality and safety standards before being authorized for sale. The PPB’s alert underscores that any product claiming to be Ozempic Pens currently available in Kenya is illegal and poses potential health risks to consumers.
The Board has emphasized that consumers should be vigilant and avoid purchasing or using these falsified products. The unauthorized presence of such medications in the market not only violates regulatory protocols but also jeopardizes public health by exposing patients to unknown substances or incorrect dosages that could have adverse effects.
Authorities are actively investigating the origins and distribution channels of these falsified Ozempic Pens to prevent further harm. The PPB urges healthcare professionals, pharmacists, and the public to report any suspicious products or activities related to these pens to facilitate swift action against those responsible for their illegal sale.
Furthermore, the PPB reassures the public that genuine Ozempic Pens, when properly authorized and obtained through licensed channels, adhere to strict quality standards and are safe for use as prescribed by healthcare providers. Patients currently using Ozempic or considering its use should consult their healthcare professionals to ensure they receive legitimate and regulated medications.
In conclusion, the PPB’s alert serves as a crucial reminder of the risks associated with falsified medical products entering the market. It underscores the importance of regulatory oversight in safeguarding public health and urges consumers to exercise caution and verify the authenticity of medications before purchase. By raising awareness and taking decisive action against illegal products, the PPB aims to protect the well-being of all Kenyan citizens relying on essential healthcare treatments like Ozempic Pens.
